David Young • September 29, 2014
A former PIMCO executive explains how cultural changes under Mohamed El-Erian led to Bill Gross’s decision to bolt from the bond giant.
Julie Segal • September 26, 2014
Bill Gross’s abrupt decision to leave PIMCO for Janus Capital doesn’t bode well for bond investors.
David Rothnie • September 25, 2014
Former head of U.K. Financial Investments, Robin Budenberg brings valuable experience to the investment and advisory firm’s London office.
Michael Peltz • September 25, 2014
Moody's CEO Ray McDaniel has broadened the company's business to profit from the increased focus on risk management in the wake of the financial crisis.
Georgina Hurst • September 23, 2014
The South American country’s latest default could leave custodians reluctant to get involved in sovereign debt restructurings.
S.L. Mintz • September 19, 2014
In our most recent quarterly Corporate Buyback Scorecard, companies struggle with high stock prices and other uses for spare cash, including M&A.
Aaron Timms • September 18, 2014
Demand appears strong for Chinese e-commerce giant’s stock, but IPO’s record size and peculiar features could make for volatile early trading.
Allen T. Cheng • September 12, 2014
Singapore’s DBS Bank, which just helped Alibaba acquire a stake in Singapore Post, sees growing business from mainland firms.
Craig Mellow • September 12, 2014
Search provider Yandex continues to enjoy robust growth, but the Ukraine crisis hits stock price and causes a big foreign exchange write-off.
Fiona Reynolds • September 10, 2014
A company’s performance on environmental, social and governance issues should be a key factor in determining C-suite pay.
The Staff • September 06, 2014
Citadel’s Ken Griffin gets divorced; venture capitalist Tim Draper pushes six Californias; tycoon Tony Fung bets on a new Macau in Australia; and more.
Dan Weil • September 05, 2014
The prices paid by TV and cable networks for the right to broadcast live sports have skyrocketed, prompting talk of a bubble.
Michael Peltz • September 03, 2014
Valeant Pharmaceuticals CEO Pearson’s $53 billion hostile bid to buy rival Allergan is the latest move by the former McKinsey consultant, who believes that capital is better spent on acquisitions than on R&D.
The Editors • August 31, 2014
PIMCO on navigating the U.S. mortgage market, BlackRock’s macro outlook and more, from AllianceBernstein, Investec, KKR and J.P. Morgan Asset Management.
Russell Sherman • August 31, 2014
The former Bear Stearns CEO passed away this summer, but his magical and multifaceted impact on the many who knew him will long live on.
Udayan Gupta • August 30, 2014
Venture capital funds have been actively investing and generating high returns, but most institutional investors don’t seem to be impressed.
Allen T. Cheng • August 28, 2014
Mainland firms are stepping up the pace of foreign acquisitions, increasingly targeting technology and consumer plays in developed countries.
David Rothnie • August 25, 2014
The U.S. bank’s chairman of corporate and investment banking for continental Europe is making his native Italy a priority.
Aaron Timms • July 24, 2014
Stan Druckenmiller believes inversions present an opportunity to pursue broader reform of the U.S. tax system, tax hikes included.
Tom Buerkle • July 23, 2014
The Irish entrepreneur is spending heavily to develop his mobile network in the Caribbean and Pacific — and to give back to the community.
© 2014 Institutional Investor LLC. All material subject to strictly enforced copyright laws.
Please read our
Term and Conditions and